ArticleEJNMMI research2014

The La antigen is over-expressed in lung cancer and is a selective dead cancer cell target for radioimmunotherapy using the La-specific antibody APOMAB®.

Alexander H Staudacher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.